Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$2.9M
4 rounds on record
Latest round
$2.9M
Venture round · Sep 2022 · 4 yr ago
Team
11-50
employees, estimated range
Grants
$1.8M
3 grants · CORDIS
The money's age
Long since its last round
48 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 24 Won a grant $1.3M · CORDIS May 9, 2024 Won a grant $296k · CORDIS Jan 15, 2024 Won a grant $275k · CORDIS Sep 20, 2022 Raised a round Venture round $2.9M · SEC Form D 2020 Founded
Funding rounds
RoundDateAmountInvestorsSource
Grant Jul 2026 $1.3M — CORDIS
Grant May 2024 $296k — CORDIS
Grant Jan 2024 $275k — CORDIS
Venture round Sep 2022 $2.9M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity MelliCell, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Benjamin PopeExecutive Officer, DirectorSEC Form D
Prince NnahExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
ORF BiologicsVenture round $1.7M · 2 mo ago • Founded 2024 • 1-10 employees
ORF Biologics pioneers next-generation biologics and cutting-edge technologies for research and therapeutic applications.
Build next-generation cell engineering and drug discovery workflows with Portal mechanoporation for broad intracellular delivery across…
GravTech SolutionsFounded 2025
Unlocking Earth's Resources with Next-Generation Gravity Sensing. GravTech Solutions pioneers next-generation geophysical surveys using…
Prolific MachinesSeries B $55M · 2 yr ago • Founded 2020 • 51-200 employees • 4 roles
Difficult protein production made simple. A next-generation expression system for next-generation therapeutics.
Continuity BiosciencesVenture round $8.4M · 14 mo ago • Founded 2023 • 1-10 employees
Continuity Biosciences builds adaptive combination products for precision therapeutic delivery — advancing oncology, cell therapy, and…
General Proximity11-50 employees
General Proximity pioneers next-generation medicines by controlling biological processes through proximity. Redefining the future of…

Overview

MelliCell Inc. pioneers next-generation therapeutics for chronic diseases like diabetes and obesity through advanced fat cell engineering.

People

Benjamin Pope
Executive Officer, Director
Prince Nnah
Executive Officer, Director
Todd Spalding
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Newton United States
HQ
10-50 est. staff

Financials

Total raised
$4.7M
Latest round
Grant
Funding rounds
4
Funding rounds
Round Announced Amount
Grant 2026 $1.3M Details
Grant 2024 $296k Details
Grant 2024 $275k Details
Venture - Series Unknown 2022 $2.9M Details